CIK 0001367644 · Accelerated filer
Emergent BioSolutions Inc.
Sign in to watch- Ticker
- EBS
- Exchange
- NYSE
- Industry
- Pharmaceutical Preparations
- FY end
- Dec 31
- Incorporated
- DE
- Entity type
- operating
- EIN
- 141902018
- Phone
- 240-631-3200
- Business address
- 300 PROFESSIONAL DR, GAITHERSBURG, MD, 20879
- DEF 14A Proxy Proxy Statement
- 4 Derivatives Options or other derivatives
- 4 Shares withheld for taxes President and CEO gave up 37,055 shares (to pay taxes)
- 4 Grant or award Director acquired 5,006 shares (grant or award)
- 3 Insider Initial Statement of Ownership
- 4 Shares withheld for taxes SVP, R&D, CMO gave up 10,636 shares (to pay taxes)
- 4 Shares withheld for taxes SVP, Bioservices gave up 9,493 shares (to pay taxes)
- 4 Shares withheld for taxes SVP, General Counsel, Corp Sec gave up 6,465 shares (to pay taxes)
- 4 Shares withheld for taxes SVP, Products Business gave up 9,397 shares (to pay taxes)
- 4 Shares withheld for taxes EVP, Chief Financial Officer gave up 23,650 shares (to pay taxes)
- 4 Shares withheld for taxes EVP, Quality & Ethics, and CPL gave up 8,199 shares (to pay taxes)
- 4 Shares withheld for taxes SVP, Products Business gave up 116 shares (to pay taxes)
- 4 Shares withheld for taxes EVP, Chief Financial Officer gave up 683 shares (to pay taxes)
- 4 Shares withheld for taxes EVP, Quality & Ethics, and CPL gave up 313 shares (to pay taxes)
- 8-K Event Executive or director change · Regulation FD disclosure
- 10-K Report Annual Report
- 8-K Event Results of operations · Regulation FD disclosure
- 4 Shares withheld for taxes SVP, General Counsel, Corp Sec gave up 918 shares (to pay taxes)
- 4 Returned to the company EVP, Quality & Ethics, and CPL returned 28,847 shares (to the company)
- 4 Returned to the company SVP, Products Business returned 8,655 shares (to the company)
Page 4 of 87 · 1,733 filings